Ultrasound‑triggered herceptin liposomes for breast cancer therapy
The functionalization of liposomes with monoclonal antibodies is a potential strategy to increase the specificity of liposomes and reduce the side-effects associated with chemotherapeutic agents. The active targeting of the Human Epidermal growth factor Receptor 2 (HER2), which is overexpressed in H...
محفوظ في:
| المؤلف الرئيسي: | Elamir, Amal (author) |
|---|---|
| مؤلفون آخرون: | Ajith, Saniha Aysha (author), AlSawaftah, Nour Majdi (author), Abuwatfa, Waad Hussein (author), Mukhopadhyay, Debasmita (author), Paul, Vinod (author), Al-Sayah, Mohammad (author), Awad, Nahid S. (author), Husseini, Ghaleb (author) |
| التنسيق: | article |
| منشور في: |
2021
|
| الوصول للمادة أونلاين: | http://hdl.handle.net/11073/21389 |
| الوسوم: |
إضافة وسم
لا توجد وسوم, كن أول من يضع وسما على هذه التسجيلة!
|
مواد مشابهة
-
Ultrasound Triggering of Liposomal Nanodrugs for Cancer Therapy: A Review
حسب: Bahutair, Wafa N.
منشور في: (2022) -
Ultrasound triggered release of Trastuzumab-conjugated immunoliposomes targeting breast cancer
حسب: Ahmed, Amal Elsadig Elamir
منشور في: (2018) -
Targeting Breast Cancer Using Hyaluronic Acid-Conjugated Liposomes Triggered with Ultrasound
حسب: Ben-Daya, Mohamed
منشور في: (2021) -
Ultrasonically Triggered Release of Folic Acid-Conjugated Liposomes for Breast Cancer Therapy Within Microfluidic Devices
حسب: AlHazaimeh, Taima Khair Alla
منشور في: (2024) -
Ultrasound Triggered Release of Estrone- Targeted Liposomes
حسب: Kawak, Pierre
منشور في: (2017)